(Q45869026)

17 December 2017

title

Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors (English)

1 reference

17 December 2017

author name string

James B Wechuck

1

1 reference

17 December 2017

Ali Ozuer

2

1 reference

17 December 2017

William F Goins

3

1 reference

17 December 2017

Darren Wolfe

4

1 reference

17 December 2017

Thomas Oligino

5

1 reference

17 December 2017

Joseph C Glorioso

6

1 reference

17 December 2017

Mohammad M Ataai

7

1 reference

17 December 2017

publication date

1 July 2002

1 reference

17 December 2017

Biotechnology and Bioengineering

published in

1 reference

17 December 2017

volume

79

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

112-119

1 reference

17 December 2017

Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle

cites work

1 reference

Gene therapy scores against cancer

21 January 2018

1 reference

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

21 January 2018

1 reference

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

21 January 2018

1 reference

Effects of long-term passaging of BTI-Tn5B1-4 insect cells on growth and recombinant protein production

21 January 2018

1 reference

Studies of defective herpes simplex viruses

21 January 2018

1 reference

Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion

21 January 2018

1 reference

Kinetic analyses of stability of simple and complex retroviral vectors

21 January 2018

1 reference

Optimized conditions for the production of recombinant amphotropic retroviral vector preparations

21 January 2018

1 reference

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

21 January 2018

1 reference

Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer

21 January 2018

1 reference

Improved methods of retroviral vector transduction and production for gene therapy

21 January 2018

1 reference

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

21 January 2018

1 reference

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

Effect of pH on the kinetics of herpes simplex virus inactivation at 36°

21 January 2018

1 reference

Physical integrity of herpes simplex virus following thermal inactivation

21 January 2018

1 reference

Thermal-pH inactivation of herpes simplex virus: interdependence of the medium composition and the pH on the rate of virus inactivation. Brief report

21 January 2018

1 reference

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

21 January 2018

1 reference

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

Interference of the low-pH inactivated herpes simplex virus type 1 (HSV-1) strain HSZP with the early shutoff function of superinfecting HSV-1 strain KOS.

21 January 2018

1 reference

The primary production of an infectious recombinant Herpes Simplex Virus vaccine

21 January 2018

1 reference

Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors

21 January 2018

1 reference

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

Gene therapy: trials and tribulations

21 January 2018

1 reference

Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

21 January 2018

1 reference

Effect of protease inhibitors on yield of HSV-1-based viral vectors

21 January 2018

1 reference

Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models

21 January 2018

1 reference

Herpesvirus-mediated systemic delivery of nerve growth factor

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIT.10310

1 reference

17 December 2017

1 reference

17 December 2017